Ans De Beuckelaer

Ans De Beuckelaer has a diverse work experience. They began their career at Universiteit Gent in 2012, where they worked on their PhD focusing on mRNA-based vaccines to elicit CD8 T cell immunity. This research explored the effect of type I interferons on CD8+ T cell immunity to mRNA vaccines. They completed their PhD in December 2016.

After their PhD, Ans De Beuckelaer joined NLO as a Trainee Patent Attorney from February 2017 to January 2018. Here, they gained experience in patent law and intellectual property.

In 2018, Ans De Beuckelaer joined BARC Global Central Laboratory as a Principal Scientist. They held this role for two years, from February 2018 to December 2020. During this time, they likely conducted scientific research and provided expertise in their field.

In December 2020, Ans De Beuckelaer joined Cerba Research as the EU Regional Head Flow Cytometry. They held this position until June 2023 when they were promoted to Head of Scientific Operations. As Head of Scientific Operations, they are responsible for overseeing the scientific operations of the company.

Overall, Ans De Beuckelaer has gained expertise in scientific research, intellectual property, and scientific operations throughout their career.

Ans De Beuckelaer completed their education in the field of Biochemistry and Biotechnology. They began their academic journey at Sint Theresia college from 2004 to 2010, focusing on Wetenschappen wiskunde. Following this, Ans attended Ghent University from 2007 to 2010, obtaining a Bachelor of Science (M.Sc.) degree in Biochemistry and Biotechnology. They continued their studies at Ghent University, completing a Master of Science (M.S.) degree in Biochemistry and Biotechnology from 2010 to 2012. Ans then pursued further education, earning a Doctor of Science in Biochemistry and Biotechnology from Universiteit Gent in December 2016.